Hempstract Insiders

Hempstract employs about 2 people. The company is managed by 3 executives with a total tenure of roughly 5 years, averaging almost 1.0 years of service per executive, having 0.67 employees per reported executive. Breaking down Hempstract's management performance can provide insight into the firm performance.
Michael Glazer  Insider
Sec
Ronald Herzfeld  Insider
CEO Director
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

Hempstract Workforce Comparison

Hempstract is rated below average in number of employees category among its peers. The total workforce of Drug Manufacturers—Specialty & Generic industry is currently estimated at about 801. Hempstract adds roughly 2.0 in number of employees claiming only tiny portion of equities under Drug Manufacturers—Specialty & Generic industry.
The company has Profit Margin (PM) of (0.35) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.4) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.4.

Hempstract Notable Stakeholders

A Hempstract stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Hempstract often face trade-offs trying to please all of them. Hempstract's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Hempstract's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.

About Hempstract Management Performance

The success or failure of an entity such as Hempstract often depends on how effective the management is. Hempstract management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Hempstract management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Hempstract management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Hempstract, Inc. produces and sells cannabidiol and cannabigerol solutions in the United States. The company was formerly known as Riverdale Oil and Gas Corporation and changed its name to Hempstract, Inc. in November 2020. Hempstract is traded on OTC Exchange in the United States.
Please note, the imprecision that can be found in Hempstract's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Hempstract. Check Hempstract's Beneish M Score to see the likelihood of Hempstract's management manipulating its earnings.

Hempstract Workforce Analysis

Traditionally, organizations such as Hempstract use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Hempstract within its industry.

Hempstract Manpower Efficiency

Return on Hempstract Manpower

Revenue Per Employee6.3K
Revenue Per Executive4.2K
Net Loss Per Employee2.2K
Net Loss Per Executive1.5K
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.

Other Consideration for investing in Hempstract Pink Sheet

If you are still planning to invest in Hempstract check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Hempstract's history and understand the potential risks before investing.
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets